Drug Chatter -- Tracking biopharma stock chatter

Profile for Adamas Pharmaceuticals, Inc. (ADMS)

« Back to company index

ADMS Chatter Timeline

Stock Ticker for ADMS

Most Active Tweeters for ADMS

UserTweets
@CFinancialNews 11
@intercooleronli 10
@TheMarketsDaily 7
@storminvestor 6
@TickerReport 6

Recent Tweets for ADMS

tradeRussian @tradeRussian
$ADMS may pop lil with pipers new pt of $30
September 25th 2017, 9:09am
dailymailtimes @dailymailtimes
Adamas Pharmaceuticals, Inc. $ADMS Raised to Hold at Zacks Investment Research https://t.co/khnEvJTKsj
September 25th 2017, 4:09am
midetimes @midetimes
Adamas Pharmaceuticals, Inc. $ADMS Raised to Hold at Zacks Investment Research https://t.co/pU0TJhWJ4a
September 25th 2017, 4:09am
dailypoliticaln @dailypoliticaln
Adamas Pharmaceuticals, Inc. $ADMS Raised to Hold at Zacks Investment Research https://t.co/4aL3PxeJjN
September 25th 2017, 4:09am
WKRBNews @WKRBNews
Adamas Pharmaceuticals, Inc. $ADMS Raised to Hold at Zacks Investment Research https://t.co/REVx09kXJQ
September 25th 2017, 4:09am
SleekMoneycom @SleekMoneycom
Adamas Pharmaceuticals $ADMS Given Daily Media Sentiment Rating of 0.22 https://t.co/AErpMGg0IA
September 24th 2017, 4:09pm
Neon68 @Neon68
@johnscharts i hate this, had the same with $ADMS
September 24th 2017, 12:09pm
TheMarketsDaily @TheMarketsDaily
Adamas Pharmaceuticals, Inc. $ADMS Raised to Hold at Zacks Investment Research https://t.co/rTbEnpI4mv
September 24th 2017, 7:09am
IRAMarketReport @IRAMarketReport
Adamas Pharmaceuticals, Inc. $ADMS Stock Rating Reaffirmed by Piper Jaffray Companies https://t.co/v3DMyyancB
September 24th 2017, 5:09am
chaffeybreeze @chaffeybreeze
Adamas Pharmaceuticals, Inc. $ADMS Stock Rating Reaffirmed by Piper Jaffray Companies https://t.co/c8etAMJmUC
September 24th 2017, 5:09am
TickerReport @TickerReport
Adamas Pharmaceuticals, Inc. to Post Q3 2017 Earnings of -$0.93 Per Share, William Blair Forecasts $ADMS https://t.co/6E7h8P9mHm
September 24th 2017, 1:09am
emq_news @emq_news
Adamas Pharmaceuticals, Inc. to Post Q3 2017 Earnings of -$0.93 Per Share, William Blair Forecasts $ADMS https://t.co/7xL59cBlVX
September 24th 2017, 1:09am
TickerReport @TickerReport
Adamas Pharmaceuticals, Inc. to Post Q3 2017 Earnings of -$0.93 Per Share, William Blair Forecasts $ADMS https://t.co/VipKRnuLul
September 24th 2017, 1:09am
TheMarketsDaily @TheMarketsDaily
Adamas Pharmaceuticals, Inc. $ADMS Earns “Overweight” Rating from Piper Jaffray Companies https://t.co/zeW7I4XXKN
September 23rd 2017, 9:09am
TranscriptDaily @TranscriptDaily
William Blair Brokers Boost Earnings Estimates for Adamas Pharmaceuticals, Inc. $ADMS https://t.co/Nin12Ky2DT
September 23rd 2017, 2:09am
WatchlistN @WatchlistN
Adamas Pharmaceuticals, Inc. $ADMS Rating Increased to Hold at Zacks Investment Research https://t.co/IIHaRo1MBc
September 23rd 2017, 2:09am
QLFilings @QLFilings
$ADMS filed Form 3 with the SEC. Most mentioned words: undersigned, attorney-in-fact, power, option, exchange
September 22nd 2017, 6:09pm
StockTexts @StockTexts
$ADMS Adamas Pharmaceuticals, Inc. SEC Filing: Form 3 https://t.co/tMe6oUvTU8
September 22nd 2017, 5:09pm
filingBot @filingBot
@KungPace there is a new form 3 filing for $ADMS https://t.co/MOnLnpsbH9 Tell the world!
September 22nd 2017, 5:09pm
SPNewsAnalysis @SPNewsAnalysis
Adamas Pharmaceuticals, Inc. $ADMS Upgraded to “Hold” at Zacks Investment Research https://t.co/ZwjoVpu9Rw
September 22nd 2017, 2:09pm
storminvestor @storminvestor
Adamas Pharmaceuticals, Inc. $ADMS Upgraded to “Hold” at Zacks Investment Research https://t.co/BusUBkFrJP
September 22nd 2017, 2:09pm
TickerReport @TickerReport
Adamas Pharmaceuticals, Inc. $ADMS Forecasted to Earn FY2020 Earnings of $3.62 Per Share https://t.co/mLzGXs3jub
September 22nd 2017, 1:09pm
TickerReport @TickerReport
Adamas Pharmaceuticals, Inc. $ADMS Forecasted to Earn FY2020 Earnings of $3.62 Per Share https://t.co/vVINNphuXx
September 22nd 2017, 1:09pm
emq_news @emq_news
Adamas Pharmaceuticals, Inc. $ADMS Forecasted to Earn FY2020 Earnings of $3.62 Per Share https://t.co/S9jfoLpC5B
September 22nd 2017, 1:09pm
chaffeybreeze @chaffeybreeze
Adamas Pharmaceuticals, Inc. $ADMS Earns Buy Rating from Mizuho https://t.co/rMij54LAqV
September 22nd 2017, 9:09am
IRAMarketReport @IRAMarketReport
Adamas Pharmaceuticals, Inc. $ADMS Earns Buy Rating from Mizuho https://t.co/CXhU5lw6LC
September 22nd 2017, 9:09am
WatchlistN @WatchlistN
Adamas Pharmaceuticals, Inc. $ADMS Rating Reiterated by Piper Jaffray Companies https://t.co/S99EIILLvN
September 22nd 2017, 7:09am
CFinancialNews @CFinancialNews
William Blair Brokers Lift Earnings Estimates for Adamas Pharmaceuticals, Inc. $ADMS https://t.co/0G60peZ7qY
September 22nd 2017, 7:09am
intercooleronli @intercooleronli
William Blair Brokers Lift Earnings Estimates for Adamas Pharmaceuticals, Inc. $ADMS https://t.co/MuCHsxHwFC
September 22nd 2017, 6:09am
NewsToDesk @NewsToDesk
$ADMS: Daily Technical Summary Reports on Generic Drugs Stocks …: https://t.co/1ySy4qKWir
September 22nd 2017, 6:09am
ZolmaxNews @ZolmaxNews
Zacks Investment Research Upgrades Adamas Pharmaceuticals, Inc. $ADMS to “Hold” https://t.co/1MSyew05TV
September 21st 2017, 8:09pm
CFinancialNews @CFinancialNews
Adamas Pharmaceuticals, Inc. $ADMS Lifted to Hold at Zacks Investment Research https://t.co/D5Tk0TwQjZ
September 21st 2017, 8:09pm
ZolmaxNews @ZolmaxNews
Zacks Investment Research Upgrades Adamas Pharmaceuticals, Inc. $ADMS to “Hold” https://t.co/1MSyewhGLt
September 21st 2017, 8:09pm
intercooleronli @intercooleronli
Adamas Pharmaceuticals, Inc. $ADMS Lifted to Hold at Zacks Investment Research https://t.co/Yhu1cn6CWm
September 21st 2017, 8:09pm
SleekMoneycom @SleekMoneycom
Zacks Investment Research Upgrades Adamas Pharmaceuticals, Inc. $ADMS to “Hold” https://t.co/RFRHslTWwi
September 21st 2017, 8:09pm
RatingsNetwork @RatingsNetwork
Adamas Pharmaceuticals upgraded by Zacks Investment Research to hold. https://t.co/QzhSQ63szr $ADMS #ADMS
September 21st 2017, 8:09pm
WatchlistN @WatchlistN
Analysts Set Adamas Pharmaceuticals, Inc. $ADMS PT at $36.00 https://t.co/gYNehJEzoV
September 21st 2017, 6:09pm
confcalltran @confcalltran
Departure of Directors or Certain https://t.co/ldfDOBQEDH $ADMS
September 21st 2017, 4:09pm
filingBot @filingBot
@KungPace there is a new form 8-K filing for $ADMS https://t.co/uDEUsdZq07 Fav if you like.
September 21st 2017, 4:09pm
TheMarketsDaily @TheMarketsDaily
William Blair Weighs in on Adamas Pharmaceuticals, Inc.’s FY2020 Earnings $ADMS https://t.co/dBMsL2u4YN
September 21st 2017, 4:09pm
CFinancialNews @CFinancialNews
William Blair Weighs in on Adamas Pharmaceuticals, Inc.’s FY2020 Earnings $ADMS https://t.co/qtWeqN79AL
September 21st 2017, 4:09pm
intercooleronli @intercooleronli
William Blair Weighs in on Adamas Pharmaceuticals, Inc.’s FY2020 Earnings $ADMS https://t.co/NnVC2UZpfW
September 21st 2017, 3:09pm
SPNewsAnalysis @SPNewsAnalysis
Adamas Pharmaceuticals, Inc. $ADMS Receives Overweight Rating from Piper Jaffray Companies https://t.co/HvSDdmZWZe
September 21st 2017, 12:09pm
storminvestor @storminvestor
Adamas Pharmaceuticals, Inc. $ADMS Receives Overweight Rating from Piper Jaffray Companies https://t.co/NUwyt2vZpJ
September 21st 2017, 12:09pm
Bonsai_Me @Bonsai_Me
$ENDP $ADMS Adamas Releases Pricing For GOCOVRI https://t.co/5JiQ0aPXaT
September 21st 2017, 10:09am
TranscriptDaily @TranscriptDaily
Adamas Pharmaceuticals, Inc. $ADMS Rating Reiterated by Mizuho https://t.co/dSecOuPtyX
September 21st 2017, 6:09am
dailymailtimes @dailymailtimes
Adamas Pharmaceuticals, Inc. $ADMS Shares Gap Up on Analyst Upgrade https://t.co/Zz6tSoR5Ql
September 21st 2017, 1:09am
WKRBNews @WKRBNews
Adamas Pharmaceuticals, Inc. $ADMS Shares Gap Up on Analyst Upgrade https://t.co/ayxC8SMz2X
September 21st 2017, 1:09am
midetimes @midetimes
Adamas Pharmaceuticals, Inc. $ADMS Shares Gap Up on Analyst Upgrade https://t.co/HPLGBdcrYn
September 21st 2017, 1:09am
dailypoliticaln @dailypoliticaln
Adamas Pharmaceuticals, Inc. $ADMS Shares Gap Up on Analyst Upgrade https://t.co/ystDBudNRq
September 21st 2017, 1:09am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.